Canadian Public Health Laboratory Network Statement on Point-of-Care Serology Testing in COVID-19
Canadian Public Health Laboratory Network Statement on Point-of-Care Serology Testing in COVID-19
Simple item page
Full item details
- creativework.keywords - en
- COVID-19
- serology testing
- point-of-care
- Canada
- antibodies to SARS-CoV-2
- dc.contributor.author
- Respiratory Virus Infections Working Group
- dc.date.accessioned
- 2023-06-05T15:35:34Z
- dc.date.available
- 2023-06-05T15:35:34Z
- dc.date.issued
- 2022
- dc.description.abstract - en
- Point-of-care (POC) serology tests for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), detect the human antibody response to infection or vaccination and not the virus itself. Most are qualitative immunochromatographic (lateral-flow)-based assays that detect IgG+/-IgM from a finger prick blood sample and can provide results in less than 30 minutes. While there is widespread interest in adopting POC serology tests for COVID-19, there are currently significant limitations to this testing modality, including the incomplete understanding of the immunological response in COVID-19, suboptimal clinical validation data, uncertain correlation (or lack thereof) with clinical laboratory-based serology tests and wide variability in performance among different POC tests. Many of the key points outlined below also apply to laboratory-based COVID-19 serology testing.
- dc.description.abstract-french - fr
- Les tests sérologiques au point d’intervention pour le coronavirus du syndrome respiratoire aigu sévère 2 (SRAS-CoV-2), le virus responsable de la maladie à coronavirus 2019 (COVID-19), détectent la réaction des anticorps humains à l’infection ou à la vaccination et non au virus lui-même. La plupart sont des tests qualitatifs basés sur l’immunochromatographie (flux latéral) qui détectent les IgG+/-IgM dans un échantillon de sang prélevé au doigt et dont les résultats sont disponibles en moins de 30 minutes. Bien que l’adoption de tests sérologiques aux points d’intervention pour la COVID-19 suscite un intérêt général, cette méthode de dépistage présente actuellement des limites importantes, notamment une compréhension incomplète de la réaction immunologique à la COVID-19, des données de validation clinique sous-optimales, une corrélation incertaine (ou l’absence de corrélation) avec les tests sérologiques de laboratoire clinique et une grande variabilité du rendement entre les différents tests aux points d’intervention. La plupart des points clés décrits ci-dessous s’appliquent également aux tests sérologiques COVID-19 en laboratoire.
- dc.identifier.citation
- Respiratory Virus Infections Working Group. Canadian Public Health Laboratory Network Statement on Point-of-Care Serology Testing in COVID-19. Can Commun Dis Rep 2022;48(1):1–3. https://doi.org/10.14745/ccdr.v48i01a01
- dc.identifier.doi
- https://doi.org/10.14745/ccdr.v48i01a01
- dc.identifier.issn
- 1481-8531
- dc.identifier.uri
- https://open-science.canada.ca/handle/123456789/539
- dc.language.iso
- en
- dc.publisher
- The Public Health Agency of Canada
- dc.relation.istranslationof
- https://open-science.canada.ca/handle/123456789/541
- dc.rights - en
- Creative Commons Attribution 4.0 International (CC BY 4.0)
- dc.rights - fr
- Creative Commons Attribution 4.0 International (CC BY 4.0)
- dc.rights.openaccesslevel - en
- Green
- dc.rights.openaccesslevel - fr
- Vert
- dc.rights.uri - en
- https://creativecommons.org/licenses/by/4.0/
- dc.rights.uri - fr
- https://creativecommons.org/licenses/by/4.0/deed.fr
- dc.subject - en
- Health
- dc.subject - fr
- Santé
- dc.subject.en - en
- Health
- dc.subject.fr - fr
- Santé
- dc.title - en
- Canadian Public Health Laboratory Network Statement on Point-of-Care Serology Testing in COVID-19
- dc.type - en
- Accepted manuscript
- dc.type - fr
- Manuscrit accepté
- local.article.journalissue
- 1
- local.article.journaltitle
- Canada Communicable Disease Report
- local.article.journalvolume
- 48
- local.pagination
- 1-3
- local.peerreview - en
- Yes
- local.peerreview - fr
- Oui
Download(s)
Original bundle
1 - 1 of 1
Name: CanadianPublicHealthLaboratoryNetworkStatementPoint-of-CareSerologyTestingCOVID-19.pdf
Size: 117.08 KB
Format: PDF
Collection(s)